ProMIS Neurosciences is trading at $10.02, up 6.77%, as broader market strength may be supporting the stock; no specific company catalyst for October 2 was identified.
- The S&P 500 is up 1.05%, Nasdaq 1.71%, and Dow 0.57%; supplied market context links the risk-on move to softer jobs data and lower Treasury yields.
- Shares rebounded sharply after closing October 1 at $9.38, down 13.55%. The latest company release announced October conference participation.